Skip to main content
Erschienen in: World Journal of Surgical Oncology 1/2009

Open Access 01.12.2009 | Case report

A rare coexistence of adrenal cavernous hemangioma with extramedullar hemopoietic tissue: a case report and brief review of the literature

verfasst von: Nikolaos Arkadopoulos, Maria Kyriazi, Anneza I Yiallourou, Vaia K Stafyla, Theodosios Theodosopoulos, Nikolaos Dafnios, Vassilis Smyrniotis, Agathi Kondi-Pafiti

Erschienen in: World Journal of Surgical Oncology | Ausgabe 1/2009

download
DOWNLOAD
print
DRUCKEN
insite
SUCHEN

Abstract

Background

Cavernous hemangiomas of the adrenal gland are rare, benign, non-functioning neoplastic tumors. To our knowledge, 55 cases have been reported in the literature to date.

Case presentation

We report the first case of a large, non-functioning adrenal cavernous hemangioma that was incidentally found during the preoperative staging workup of a 75 year old woman with left breast adenocarcinoma. Imaging with US, CT scan and MRI showed a heterogeneous 8 cm mass with non-specific radiological features that was located on the left adrenal gland. The mass was surgically excised and pathology revealed an adrenal hemangioma with areas of extramedullar hemopoiesis.

Conclusion

Although adrenal hemangiomas are rare and their preoperative diagnosis is difficult, they should always be included in the differential diagnosis of adrenal neoplasms.
Hinweise

Electronic supplementary material

The online version of this article (doi:10.​1186/​1477-7819-7-13) contains supplementary material, which is available to authorized users.

Competing interests

The authors declare that they have no competing interests.

Authors' contributions

NA was responsible for critical revision of scientific content. MK drafted the manuscript. AIY participated in the design of the manuscript and helped to draft the manuscript. VKS contributed substantially to manuscript conception and design. TT assisted in the preparation of the manuscript.
ND participated in the acquisition of data and preparation of the manuscript. VS was the surgeon, approved the final version of the manuscript for publication. AKP performed histopathological and immunohistochemical analysis and contributed substantially to pathology content. All authors read and approved the final manuscript.

Background

Adrenals are an infrequent location for benign vascular tumors like cavernous hemangiomas-such tumors are most commonly situated on the skin or in the liver. Their clinical presentation is usually vague, with non-specific abdominal pain being the predominant symptom. Frequently, they are discovered as incidentalomas either during imaging or in autopsies. Since 1955, when Johnson and Jeppesen described the first adrenal cavernous hemangioma, only 55 cases have been reported in the literature [1]. We report a case of a large, non-functioning adrenal hemangioma that was found incidentally during pre-operative staging of a 75 year old woman with adenocarcinoma of the left breast.

Case presentation

A 75 year old female patient with breast cancer was admitted to our hospital for surgical treatment. Her preoperative staging workup with an abdominal ultrasound, revealed a heterogeneous solid lesion of the left adrenal gland. Clinical examination and laboratory tests, including adrenal hormonal levels (plasma renin 7,40 pg/ml, plasma aldosterone 12,7 ng/dl, plasma adrenaline 27 pg/ml, plasma noradrenaline 243 pg/ml, 24 h urine metanephrine excretion 169 μg/24 h), were normal. Abdominal CT scan showed a well-defined, heterogeneous, retroperitoneal mass with speckled calcifications that measured 8 cm and was located on the left adrenal gland. After bolus IV injection of contrast medium the tumor showed irregular enhancement. On subsequent MRI, the tumor demonstrated hyperintensity on both T1- and T2-weighted images with fat component and irregular peripheral enhancement (Figure 1, 2). Malignancy could not be excluded due to the non-specific radiological features, therefore surgical resection was mandatory.
During the same operation, the patient underwent a left adrenalectomy through a left subcostal incision followed by modified radical left mastectomy. Her postoperative course was uneventful and she was discharged five days later.
On gross examination, the adrenal tumor appeared as a red tan mass measuring 8 cm × 6 cm × 4 cm. Focal red-purple hemorrhagic and cystic areas were present, along with diffuse calcifications. Normal adrenal gland parenchyma was noted on the surface of the mass (Figure 3).
Microscopically, dilated, blood filled vascular spaces were observed. The spaces were lined by a single layer of thin endothelial cells with collagenous walls (Figure 4). Interestingly, areas of extramedullar hemopoiesis were also seen (Figure 5).
The histological diagnosis was that of an adrenal cavernous hemangioma with coexistence of extramedullar hemopoiesis and no signs of malignancy.
The pathology report on the breast specimen showed a grade II infiltrating tubular adenocarcinoma, measuring 5 cm in greatest diameter. None of the 13 excised lymph nodes had signs of malignancy.

Discussion

The evolution of radiological imaging in the last 20 years resulted in increased detection rate of clinically inapparent adrenal masses, also known as adrenal incidentalomas. It is estimated that adrenal masses are an accidental finding in 1–5% of all abdominal CT scans performed. Adrenal hemangiomas, however, are extremely rare, and their differential diagnosis preoperatively is rather challenging.
Adrenal hemangiomas are most usually cavernous, unilateral lesions of the adrenal glands that appear in the sixth or seventh decade of life, with a 2:1 female to male ratio [24]. Their size ranges from 2 cm to 25 cm in diameter, with the majority measuring more than 10 cm [57]. They are most commonly non-functioning tumors, with only three cases of hormone-secreting adrenal hemangiomas being reported to date [810]. These unusual benign adrenal masses are usually detected as incidental radiological findings in abdominal imaging performed for various other reasons. They are hardly ever symptomatic, with abdominal pain due to mechanical mass effects on neighbouring structures being the main symptom. However, in two cases adrenal haemangiomas presented with spontaneous life-threatening retroperitoneal haemorrhage [3, 11]. The adrenal glands are a common site of metastasis for various cancers, therefore adrenal masses must be excluded in the preoperative staging of several carcinomas (melanomas, lung, breast, renal and gastrointestinal cancers). Three cases of adrenal hemangiomas, coexisting with malignant tumors of other organs (non-small-cell lung cancer, common bile duct cancer and gynaecological cancer) [1214] have been reported in the literature. This is the only case of adrenal hemangioma in a patient with breast cancer reported so far. Histologically, these tumors are primary mesenchymal vascular neoplasms with angioblastic cells predominating. Surprisingly, this is the only case reported with extramedullar hemopoietic tissue within a hemangioma.
Distinguishing a large adrenal hemangioma from other lesions of the adrenal glands, and especially from malignant tumors, can be very difficult. In most cases the final diagnosis is made by histopathology after surgical resection. However, there are some radiological features that, although not entirely specific, should raise the suspicion of adrenal haemangioma. CT scans usually display a characteristic peripheral patchy enhancement with progression to the centre of the tumor that is a common finding [15]. Speckled calcifications that appear throughout the mass are attributed to multiple phleboliths located in dilated vascular spaces [16, 17]. Nonetheless, this is a common finding in other adrenal lesions, such as pheochromocytoma, carcinoma and adenoma, and cannot, therefore, be pathognomonic for hemangiomas.
MRI has been proven to be the best diagnostic tool so far. The most characteristic finding is the peripheral spotty and centripetal enhancement on dynamic studies. Marked hyperintensity on T2-weighted images in combination with focal hyperintensity in T1-weighted images, indicate areas of calcification and haemorrhage that are associated with adrenal hemangiomas [2, 15, 18]. Angiography usually reveals peripheral pooling of the contrast, persisting well during the venous phase [16, 17].
The surgical indication for excision of the tumor is the size. Adrenal incidentalomas larger than 6 cm in diameter must be excised because the risk of adrenal cancer is 35% to 98%. For lesions measuring 4 cm to 6 cm, other imaging features, history of extra-adrenal malignancy, patient's preference, age and comorbitities should be taken into consideration. Adrenalectomy and follow-up with imaging are both acceptable in such cases [3]. Most adrenal hemangiomas reported so far have been treated surgically due to their size. Other indications for surgery include mass-effect type symptoms from neighbouring organs and complications, such as haemorrhage.
Adrenalectomy can be performed laparoscopically for lesions measuring less than 6 cm [7, 19]. Larger tumors, that are technically challenging and more likely to be malignant are treated preferably with open technique through an anterior (subcostal or midline incision), posterior or thoracoabdominal approach.

Conclusion

We presented a rare coexistence of an adrenal cavernous hemangioma with extramedullar hemopoietic tissue in a woman treated for breast cancer. Although rare, adrenal haemangioma should be included in the differential diagnosis of adrenal neoplasms. The main indication for surgical removal of an adrenal mass is its size. However, the risks of haemorrhage, necrosis and thrombosis necessitate surgical excision in most of the cases, especially for tumors more than 3 cm.
Written informed consent was obtained from the patient for publication of this case report and any accompanying images. A copy of the written consent is available for review by the Editor-in-Chief of this journal.
Open Access This article is published under license to BioMed Central Ltd. This is an Open Access article is distributed under the terms of the Creative Commons Attribution License ( https://​creativecommons.​org/​licenses/​by/​2.​0 ), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Competing interests

The authors declare that they have no competing interests.

Authors' contributions

NA was responsible for critical revision of scientific content. MK drafted the manuscript. AIY participated in the design of the manuscript and helped to draft the manuscript. VKS contributed substantially to manuscript conception and design. TT assisted in the preparation of the manuscript.
ND participated in the acquisition of data and preparation of the manuscript. VS was the surgeon, approved the final version of the manuscript for publication. AKP performed histopathological and immunohistochemical analysis and contributed substantially to pathology content. All authors read and approved the final manuscript.
Literatur
1.
Zurück zum Zitat Johnson CC, Jeppesen FB: Haemangioma of the adrenal. J Urol. 1955, 74: 573-577.PubMed Johnson CC, Jeppesen FB: Haemangioma of the adrenal. J Urol. 1955, 74: 573-577.PubMed
2.
Zurück zum Zitat Heis HA, Bani-Hani KE, Bani-Hani BK: Adrenal cavernous haemangioma. Singapore Med J. 2008, 49 (9): e236-e237.PubMed Heis HA, Bani-Hani KE, Bani-Hani BK: Adrenal cavernous haemangioma. Singapore Med J. 2008, 49 (9): e236-e237.PubMed
3.
4.
Zurück zum Zitat Sabanegh E, Harris MJ, Grider D: Cavernous adrenal haemangioma. Urology. 1993, 42 (3): 327-330. 10.1016/0090-4295(93)90626-L.CrossRefPubMed Sabanegh E, Harris MJ, Grider D: Cavernous adrenal haemangioma. Urology. 1993, 42 (3): 327-330. 10.1016/0090-4295(93)90626-L.CrossRefPubMed
5.
Zurück zum Zitat Makiyama K, Fukuoka H, Kawamoto K, Suwa Y: Surgical removal of adrenal haemangioma after five years of follow-up: a case report. Hinyokika Kiyo. 1998, 44: 579-581.PubMed Makiyama K, Fukuoka H, Kawamoto K, Suwa Y: Surgical removal of adrenal haemangioma after five years of follow-up: a case report. Hinyokika Kiyo. 1998, 44: 579-581.PubMed
6.
Zurück zum Zitat Hisham AN, Samad SA, Sharifah NA: Huge adrenal haemangioma. Austral Radiol. 1998, 42: 250-251. 10.1111/j.1440-1673.1998.tb00509.x.CrossRef Hisham AN, Samad SA, Sharifah NA: Huge adrenal haemangioma. Austral Radiol. 1998, 42: 250-251. 10.1111/j.1440-1673.1998.tb00509.x.CrossRef
7.
Zurück zum Zitat Nigri G, Bellagamba R, Giaccaglia V, Felicioni F, Aurello P, D' Angelo F, Del Gaudio M, Ramacciato G: Minimally invasive adrenalectomy for incidentally discovered cavernous haemangioma. Minim Invasive Ther Allied Technol. 2008, 17 (4): 255-258. 10.1080/13645700802274323.CrossRefPubMed Nigri G, Bellagamba R, Giaccaglia V, Felicioni F, Aurello P, D' Angelo F, Del Gaudio M, Ramacciato G: Minimally invasive adrenalectomy for incidentally discovered cavernous haemangioma. Minim Invasive Ther Allied Technol. 2008, 17 (4): 255-258. 10.1080/13645700802274323.CrossRefPubMed
8.
Zurück zum Zitat Stumvoll M, Fritsche A, Wehrmann M, Dammann F, Becker HD, Eggstein M: A functioning adrenocortical haemangioma. Urol. 1996, 155: 638-10.1016/S0022-5347(01)66473-5.CrossRef Stumvoll M, Fritsche A, Wehrmann M, Dammann F, Becker HD, Eggstein M: A functioning adrenocortical haemangioma. Urol. 1996, 155: 638-10.1016/S0022-5347(01)66473-5.CrossRef
9.
Zurück zum Zitat Oh BR, Jeong YY, Ryu SB, Park YI, Kang HK: A case of adrenal cavernous haemangioma. Int J Urol. 1997, 4: 608-610. 10.1111/j.1442-2042.1997.tb00318.x.CrossRefPubMed Oh BR, Jeong YY, Ryu SB, Park YI, Kang HK: A case of adrenal cavernous haemangioma. Int J Urol. 1997, 4: 608-610. 10.1111/j.1442-2042.1997.tb00318.x.CrossRefPubMed
10.
Zurück zum Zitat Ng AC, Loh HL, Shum CF, Yip SK: A case of adrenal cavernous haemangioma presenting with progressive enlargement and apparent hormonal hypersecretion. Endocr Pract. 2008, 14 (1): 104-108.CrossRefPubMed Ng AC, Loh HL, Shum CF, Yip SK: A case of adrenal cavernous haemangioma presenting with progressive enlargement and apparent hormonal hypersecretion. Endocr Pract. 2008, 14 (1): 104-108.CrossRefPubMed
11.
Zurück zum Zitat Boraschi P, Campatelli A, Di Vito A, Perri G: Haemorrhage in cavernous haemangioma of the adrenal gland: US, CT and MRI appearances with pathologic correlation. Eur J Radiol. 1995, 21 (1): 41-43. 10.1016/0720-048X(96)81068-0.CrossRefPubMed Boraschi P, Campatelli A, Di Vito A, Perri G: Haemorrhage in cavernous haemangioma of the adrenal gland: US, CT and MRI appearances with pathologic correlation. Eur J Radiol. 1995, 21 (1): 41-43. 10.1016/0720-048X(96)81068-0.CrossRefPubMed
12.
Zurück zum Zitat Alcázar J, Márquez A, Rosales M: An unusual cause of adrenal mass in a patient with operable non-small-cell pulmonary carcinoma. Arch Bronconeumol. 1998, 34 (10): 513-514.CrossRefPubMed Alcázar J, Márquez A, Rosales M: An unusual cause of adrenal mass in a patient with operable non-small-cell pulmonary carcinoma. Arch Bronconeumol. 1998, 34 (10): 513-514.CrossRefPubMed
13.
Zurück zum Zitat Päivänsalo M, Siniluoto T, Seppänen U: Cavernous haemangioma of the adrenal gland. Diagn Imaging Clin Med. 1986, 55 (3): 168-171.PubMed Päivänsalo M, Siniluoto T, Seppänen U: Cavernous haemangioma of the adrenal gland. Diagn Imaging Clin Med. 1986, 55 (3): 168-171.PubMed
14.
Zurück zum Zitat Chudácek Z, Kohoutek V: Simultaneous occurrence of a cavernous adrenal gland haemangioma and a bile duct-liver carcinoma. Rofo. 1980, 132 (4): 460-462.CrossRefPubMed Chudácek Z, Kohoutek V: Simultaneous occurrence of a cavernous adrenal gland haemangioma and a bile duct-liver carcinoma. Rofo. 1980, 132 (4): 460-462.CrossRefPubMed
15.
Zurück zum Zitat Yamada T, Ishibashi T, Saito H, Majima K, Tsuda M, Takahashi S, Moriya T: Two cases of adrenal haemangioma: CT and MRI findings with pathological correlations. Radiat Med. 2002, 20 (1): 51-56.PubMed Yamada T, Ishibashi T, Saito H, Majima K, Tsuda M, Takahashi S, Moriya T: Two cases of adrenal haemangioma: CT and MRI findings with pathological correlations. Radiat Med. 2002, 20 (1): 51-56.PubMed
16.
Zurück zum Zitat Rothberg M, Bastidas J, Mattey WE, Bernas E: Adrenal haemangiomas: angiographic appearance of a rare tumor. Radiology. 1978, 126: 341-344.CrossRefPubMed Rothberg M, Bastidas J, Mattey WE, Bernas E: Adrenal haemangiomas: angiographic appearance of a rare tumor. Radiology. 1978, 126: 341-344.CrossRefPubMed
17.
Zurück zum Zitat Thiele J, Bodie B: Adrenal haemangioma. Surgery. 2001, 1 (129): 373-374. 10.1067/msy.2001.105653.CrossRef Thiele J, Bodie B: Adrenal haemangioma. Surgery. 2001, 1 (129): 373-374. 10.1067/msy.2001.105653.CrossRef
18.
Zurück zum Zitat Marotti M, Sučić Z, Krolo I, Dimanovski J, Klarić R, Ferenčić Ž, Karapanda N, Babić N, Pavleković K: Adrenal cavernous haemangioma: MRI, CT and US appearance. Eur Radiol. 1997, 7: 691-694. 10.1007/BF02742927.CrossRefPubMed Marotti M, Sučić Z, Krolo I, Dimanovski J, Klarić R, Ferenčić Ž, Karapanda N, Babić N, Pavleković K: Adrenal cavernous haemangioma: MRI, CT and US appearance. Eur Radiol. 1997, 7: 691-694. 10.1007/BF02742927.CrossRefPubMed
19.
Zurück zum Zitat Trupka A, Hallfeldt K, Schmidbauer S: Laparoscopic adrenalectomy with lateral approach – a comparison with the conventional dorsal technique. Chirurg. 2001, 72: 1478-1484. 10.1007/s001040170014.CrossRefPubMed Trupka A, Hallfeldt K, Schmidbauer S: Laparoscopic adrenalectomy with lateral approach – a comparison with the conventional dorsal technique. Chirurg. 2001, 72: 1478-1484. 10.1007/s001040170014.CrossRefPubMed
Metadaten
Titel
A rare coexistence of adrenal cavernous hemangioma with extramedullar hemopoietic tissue: a case report and brief review of the literature
verfasst von
Nikolaos Arkadopoulos
Maria Kyriazi
Anneza I Yiallourou
Vaia K Stafyla
Theodosios Theodosopoulos
Nikolaos Dafnios
Vassilis Smyrniotis
Agathi Kondi-Pafiti
Publikationsdatum
01.12.2009
Verlag
BioMed Central
Erschienen in
World Journal of Surgical Oncology / Ausgabe 1/2009
Elektronische ISSN: 1477-7819
DOI
https://doi.org/10.1186/1477-7819-7-13

Weitere Artikel der Ausgabe 1/2009

World Journal of Surgical Oncology 1/2009 Zur Ausgabe

Wie erfolgreich ist eine Re-Ablation nach Rezidiv?

23.04.2024 Ablationstherapie Nachrichten

Nach der Katheterablation von Vorhofflimmern kommt es bei etwa einem Drittel der Patienten zu Rezidiven, meist binnen eines Jahres. Wie sich spätere Rückfälle auf die Erfolgschancen einer erneuten Ablation auswirken, haben Schweizer Kardiologen erforscht.

Hinter dieser Appendizitis steckte ein Erreger

23.04.2024 Appendizitis Nachrichten

Schmerzen im Unterbauch, aber sonst nicht viel, was auf eine Appendizitis hindeutete: Ein junger Mann hatte Glück, dass trotzdem eine Laparoskopie mit Appendektomie durchgeführt und der Wurmfortsatz histologisch untersucht wurde.

Mehr Schaden als Nutzen durch präoperatives Aussetzen von GLP-1-Agonisten?

23.04.2024 Operationsvorbereitung Nachrichten

Derzeit wird empfohlen, eine Therapie mit GLP-1-Rezeptoragonisten präoperativ zu unterbrechen. Eine neue Studie nährt jedoch Zweifel an der Notwendigkeit der Maßnahme.

Ureterstriktur: Innovative OP-Technik bewährt sich

19.04.2024 EAU 2024 Kongressbericht

Die Ureterstriktur ist eine relativ seltene Komplikation, trotzdem bedarf sie einer differenzierten Versorgung. In komplexen Fällen wird dies durch die roboterassistierte OP-Technik gewährleistet. Erste Resultate ermutigen.

Update Chirurgie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.

S3-Leitlinie „Diagnostik und Therapie des Karpaltunnelsyndroms“

Karpaltunnelsyndrom BDC Leitlinien Webinare
CME: 2 Punkte

Das Karpaltunnelsyndrom ist die häufigste Kompressionsneuropathie peripherer Nerven. Obwohl die Anamnese mit dem nächtlichen Einschlafen der Hand (Brachialgia parästhetica nocturna) sehr typisch ist, ist eine klinisch-neurologische Untersuchung und Elektroneurografie in manchen Fällen auch eine Neurosonografie erforderlich. Im Anfangsstadium sind konservative Maßnahmen (Handgelenksschiene, Ergotherapie) empfehlenswert. Bei nicht Ansprechen der konservativen Therapie oder Auftreten von neurologischen Ausfällen ist eine Dekompression des N. medianus am Karpaltunnel indiziert.

Prof. Dr. med. Gregor Antoniadis
Berufsverband der Deutschen Chirurgie e.V.

S2e-Leitlinie „Distale Radiusfraktur“

Radiusfraktur BDC Leitlinien Webinare
CME: 2 Punkte

Das Webinar beschäftigt sich mit Fragen und Antworten zu Diagnostik und Klassifikation sowie Möglichkeiten des Ausschlusses von Zusatzverletzungen. Die Referenten erläutern, welche Frakturen konservativ behandelt werden können und wie. Das Webinar beantwortet die Frage nach aktuellen operativen Therapiekonzepten: Welcher Zugang, welches Osteosynthesematerial? Auf was muss bei der Nachbehandlung der distalen Radiusfraktur geachtet werden?

PD Dr. med. Oliver Pieske
Dr. med. Benjamin Meyknecht
Berufsverband der Deutschen Chirurgie e.V.

S1-Leitlinie „Empfehlungen zur Therapie der akuten Appendizitis bei Erwachsenen“

Appendizitis BDC Leitlinien Webinare
CME: 2 Punkte

Inhalte des Webinars zur S1-Leitlinie „Empfehlungen zur Therapie der akuten Appendizitis bei Erwachsenen“ sind die Darstellung des Projektes und des Erstellungswegs zur S1-Leitlinie, die Erläuterung der klinischen Relevanz der Klassifikation EAES 2015, die wissenschaftliche Begründung der wichtigsten Empfehlungen und die Darstellung stadiengerechter Therapieoptionen.

Dr. med. Mihailo Andric
Berufsverband der Deutschen Chirurgie e.V.